美国 · 平台与数据 · Stocktwits
RAPP Stock Tempers Premarket Gains On Concerns Over Higher Discontinuation Rates In Bipolar Mania Study
The drug met its primary trial goal, producing a statistically significant 3.1-point improvement over placebo on a standard clinician-rated scale that measures the severity of…
在 Stocktwits 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (stocktwits.com)
